company background image
HLS

Healius ASX:HLS Stock Report

Last Price

AU$3.36

Market Cap

AU$1.9b

7D

-2.9%

1Y

-31.8%

Updated

24 Sep, 2022

Data

Company Financials +

Healius Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Healius
Historical stock prices
Current Share PriceAU$3.36
52 Week HighAU$5.54
52 Week LowAU$3.36
Beta1.1
1 Month Change-11.58%
3 Month Change-9.92%
1 Year Change-31.85%
3 Year Change4.35%
5 Year Change9.09%
Change since IPO140.00%

Recent News & Updates

Shareholder Returns

HLSAU HealthcareAU Market
7D-2.9%-4.6%-2.7%
1Y-31.8%-20.7%-11.0%

Return vs Industry: HLS underperformed the Australian Healthcare industry which returned -20.7% over the past year.

Return vs Market: HLS underperformed the Australian Market which returned -11% over the past year.

Price Volatility

Is HLS's price volatile compared to industry and market?
HLS volatility
HLS Average Weekly Movement3.6%
Healthcare Industry Average Movement5.2%
Market Average Movement9.6%
10% most volatile stocks in AU Market16.9%
10% least volatile stocks in AU Market4.3%

Stable Share Price: HLS is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: HLS's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199411,000Malcolm Parmenterhttps://www.healius.com.au

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through four segments: Pathology, Imaging, Day Hospitals, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services.

Healius Limited Fundamentals Summary

How do Healius's earnings and revenue compare to its market cap?
HLS fundamental statistics
Market CapAU$1.92b
Earnings (TTM)AU$294.00m
Revenue (TTM)AU$2.34b

6.5x

P/E Ratio

0.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
HLS income statement (TTM)
RevenueAU$2.34b
Cost of RevenueAU$1.33b
Gross ProfitAU$1.00b
Other ExpensesAU$710.50m
EarningsAU$294.00m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.51
Gross Margin42.99%
Net Profit Margin12.58%
Debt/Equity Ratio31.5%

How did HLS perform over the long term?

See historical performance and comparison

Dividends

4.8%

Current Dividend Yield

32%

Payout Ratio